Masimo | MASI - Ebit


Masimo reported $83.7M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Abbott USD 2.54B 358M Dec/2025
Align Technology USD 184.65M 21.61M Sep/2025
AtriCure USD 208K 4.03M Sep/2025
Avanos Medical USD 18.97M 72.63M Sep/2025
Baxter International USD 201.2M 70.8M Sep/2025
Becton, Dickinson and Co. USD 826M 153M Sep/2025
Boston Scientific USD 1.04B 98M Sep/2025
Dexcom USD 242.5M 3.3M Sep/2025
Edwards Lifesciences USD 425.1M 5.8M Sep/2025
General Electric Aerospace USD 1.68B 429M Dec/2025
Globus Medical USD -117.52M 8.43M Sep/2025
Haemonetics USD 81.1M 10.26M Sep/2025
Insulet USD 117.7M 3.4M Sep/2025
Integra LifeSciences USD 11.76M 521.67M Sep/2025
Intuitive Surgical USD 865.3M 97.5M Dec/2025
Masimo USD 83.7M 19.2M Sep/2025
Medtronic USD 1.7B 100M Sep/2025
Owens Minor USD 61.29M 34.09M Mar/2025
ResMed USD 497.6M 35.25M Dec/2025
Steris USD 270.9M 45.6M Sep/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD -22.86M 9M Sep/2025
Teleflex USD 112.65M 44.3M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Zimmer Biomet Holdings USD 338.3M 58.1M Sep/2025